Pfizer, Inc.

Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety (2020) Markman JD, Bolash RB, Mcalindon TE, Kivitz AJ, Pombo-Suarez M, Ohtori S, Roemer F, et al. Journal article Determinants of Successful Use of Sirolimus in Renal Transplant Patients (2020) Naik MG, Jürgensen JS, Arns W, Basic E, Budde K, Eitner F, Fischereder M, et al. Journal article Predictors of Delayed Response to Tofacitinib: Results of the OCTAVE Open Study for Delayed Responders (2019) Regueiro M, Kinnucan JA, Ungaro R, Quirk D, Su C, Lawendy N, Fan H, et al. Conference contribution Next-generation DNA sequencing (NGS) results for tumours from phase II ABRAZO study of talazoparib after platinum or cytotoxic non-platinum regimens in patients (pts) with advanced breast cancer (ABC) and germline BRCA1/2 (gBRCA) mutations (2019) Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, et al. Conference contribution Impact of objective response (OR) on patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA) mutation in the phase III EMBRACA trial (2019) Fasching P, Quek RGW, Bhattacharyya H, Hurvitz SA, Rugo HS, Ettl J Conference contribution Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY (2018) Buchfelder M, Van Der Lely AJ, Biller BMK, Webb SM, Brue T, Strasburger CJ, Ghigo E, et al. Journal article Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial (2018) Hurvitz SA, Quek RGW, Turner NC, Telli ML, Rugo HS, Mailliez A, Ettl J, et al. Journal article Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly (2017) Van Der Lely AJ, Gomez R, Pleil A, Badia X, Brue T, Buchfelder M, Burman P, et al. Journal article Assignment of weight-based antibody units for four additional serotypes to a human anti-pneumococcal standard reference serum 007sp (2017) Goldblatt D, Mckeen A, Burbidge P, Mcelhiney S, Mclaughlin L, Johnson A, Rauh M, Giardina PC Journal article Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic (2017) O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, et al. Journal article